Posts tagged Benjamin Zegarelli.
Blogs
3 minute read
Earlier this year, FDA released draft guidance the pharmaceutical and medical device industries had been awaiting for five years. But instead of revolutionizing the Agency's thinking on drug and device promotion, FDA's social media guidance essentially continued the familiar credo on advertisements—accurate and not misleading, fair balance, substantiation—and ignored some of the central features of social media. Last week, FDA reopened the comment period for the character-space limited communications and correcting third-party misinformation guidances. Now ...
Blog Editors
Recent Updates
- Seventh Circuit Ruling Paves the Way for More Flexible Healthcare Marketing Services
- CMS Tells States “No More” Medicaid Section 1115 Matching Funds for Designated State Health Programs (DSHP) and Designated State Investment Programs (DSIP)
- Podcast: Executive Actions Impact Federally Funded Research - What Institutions Should Do Now – Diagnosing Health Care
- A Closer Look at Proposed Changes to Medicare Advantage in the “No UPCODE Act”
- Green Commercial Leases